Chronic hyperinsulinaemia in T2DM patients leads to elevated levels of insulin-like growth factor (IGF), which includes IGF-1 and IGF-2, a class of peptides structurally similar to insulin, and its related receptors, such as IGF-1R and IGF-2R. The gene discussed is IGF1R; the disease is type 2 diabetes mellitus.